The Benefit Of Hindsight: Strategic Leadership Lessons From Pharma’s Past CEOs
Could Jimenez And Hassan’s Experience Shine A Light For Boerner And Peers?
Executive Summary
As big pharma braces for a new wave of patent expiries, we speak to two former industry chiefs – Novartis’s Joe Jimenez and Schering-Plough’s Fred Hassan – about the approach they took in similar circumstances.